UY29592A1 - AMINOPIRIMIDINS AS KINASE MODULATORS - Google Patents

AMINOPIRIMIDINS AS KINASE MODULATORS

Info

Publication number
UY29592A1
UY29592A1 UY29592A UY29592A UY29592A1 UY 29592 A1 UY29592 A1 UY 29592A1 UY 29592 A UY29592 A UY 29592A UY 29592 A UY29592 A UY 29592A UY 29592 A1 UY29592 A1 UY 29592A1
Authority
UY
Uruguay
Prior art keywords
compounds
trkb
kit
flt3
aminopirimidins
Prior art date
Application number
UY29592A
Other languages
Spanish (es)
Inventor
Michael David Gaul
Guozhang Xu
Christian Andrew Baumann
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY29592A1 publication Critical patent/UY29592A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a compuestos aminopirimidínicos de Fórmula I: donde R3, B,Z,Q,p y R1 son lo definido en la presente, al uso de tales compuestos como moduladores de proteína tirosina quinasas, en particular inhibidores de FLT3 y/o c-Kit y/oTrKB, al uso de tales compuestos para reducir o inhibir la actividad de quinasa de FLT3 y/o c-Kit y/o TrKB en una célula o un sujeto, y al uso de tales compuestos para prevenir o tratar en un sujeto un trastorno proliferativo celular y/o trastornos relacionados con FLT3 y/o c-Kit y/o TrKB. La presente invención además se refiere a composiciones farmacéuticas que comprenden los compuestos de la presente invención y a métodos para tratar afecciones tales como cánceres y otros trastornos proliferativos celulares.The invention relates to aminopyrimidine compounds of Formula I: wherein R3, B, Z, Q, and R1 are defined herein, to the use of such compounds as protein tyrosine kinase modulators, in particular FLT3 and / or c inhibitors. -Kit and / or TrKB, to the use of such compounds to reduce or inhibit the kinase activity of FLT3 and / or c-Kit and / or TrKB in a cell or a subject, and to the use of such compounds to prevent or treat in a subject a cell proliferative disorder and / or disorders related to FLT3 and / or c-Kit and / or TrKB. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as cancers and other cell proliferative disorders.

UY29592A 2005-06-10 2006-06-08 AMINOPIRIMIDINS AS KINASE MODULATORS UY29592A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68971705P 2005-06-10 2005-06-10
US65108405P 2005-12-16 2005-12-16

Publications (1)

Publication Number Publication Date
UY29592A1 true UY29592A1 (en) 2006-10-02

Family

ID=38813184

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29592A UY29592A1 (en) 2005-06-10 2006-06-08 AMINOPIRIMIDINS AS KINASE MODULATORS

Country Status (1)

Country Link
UY (1) UY29592A1 (en)

Similar Documents

Publication Publication Date Title
ECSP077994A (en) AMINOPIRIMIDINS AS KINASE MODULATORS
ECSP077991A (en) AMINOPIRIMIDINS AS KINASE MODULATORS
UY29588A1 (en) KINASE MODULATORS WITH ALQUILQUINOLINA AND ALQUILQUINAZOLINA STRUCTURES
ECSP077998A (en) AMINOQUINOLINE AND AMINOQUINAZOLINE KINASE MODULATORS
UY30041A1 (en) TRIAZOLOPIRIDAZINAS AS KINASE MODULATORS
NI200700311A (en) DERIVATIVES OF TIENOPIRIMIDINE AND TIENOPIRIDINE AS INHIBITORS OF THE FLT-3 KINASE
CU20070160A7 (en) PIRROLOPIRAZOLES, POWERFUL QUINASA INHIBITORS
EA201100425A1 (en) PIKOLINAMIDA DERIVATIVES AS KINASE INHIBITORS
EA200901133A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
ECSP088558A (en) CARBONILAMINO PIRROLOPIRAZOLES, POWERFUL INHIBITORS OF QUINASA
TW200621721A (en) Methods of preparing indazole compounds
CL2012003637A1 (en) Compounds derived from substituted quinazoline or triazolopyridine, selective tyrosine kinase inhibitors; medicine; pharmaceutical composition; and its use to treat, prevent or improve retinal / macular edema, age-related macular degeneration and retinal vascular effusion related to ischemia, among others.
EA200702136A1 (en) COMPANIES OF STANNSOPORFIN AND THEIR APPLICATION
GT200600250A (en) KINASE MODULATORS WITH ALQUILQUINOLINA AND ALQUILQUINAZOLINA STRUCTURES CROSSED REFERENCE WITH RELATED APPLICATIONS
UY29592A1 (en) AMINOPIRIMIDINS AS KINASE MODULATORS
UY29587A1 (en) AMINOQUINOLINE AND AMINOQUINAZOLINE QUINASA MODULATORS